Andere Sprachen Arecor Therapeutics plc

Aktien

A3CRY2

GB00BMWLM973

AREC

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:08 31.05.2024			% 5 Tage	% 1. Jan.
159 ^GBX	+0,95 %		+0,32 %	-12,88 %

21.05.	Transcript : Arecor Therapeutics plc - Special Call
20.05.	Arecor Therapeutics plc gibt seine ultra-konzentrierten, ultra-schnell wirkenden Insuline bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Transcript : Arecor Therapeutics plc - Special Call	21.05.
Arecor Therapeutics plc Announces Its Ultra-Concentrated, Ultra-Rapid Acting Insulins	20.05.
Arecor Therapeutics' Investigational Insulin Shows Fast Absorption in Early-stage Study	20.05.
Arecor Therapeutics hails positive profile for insulin AT278	20.05.
EARNINGS AND TRADING: Michelmersh continues with positive order intake	16.05.
Transcript : Arecor Therapeutics plc, 2023 Earnings Call, May 16, 2024	16.05.
Earnings Flash (AREC.L) ARECOR THERAPEUTICS Posts FY23 Revenue GBP4.6M	16.05.
Arecor Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	16.05.
Arecor Therapeutics collaborates with Medtronic on novel insulin	09.05.
Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development	09.05.
Arecor and Medtronic Diabetes Collaboration	09.05.
Arecor Therapeutics delays publication of 2023 results	03.05.
Arecor Therapeutics plc Announces Delay in Publication of the Group's Final Results for the Year Ended 31 December 2023	03.05.
Arecor chief financial officer to leave in July after five years	23.04.
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Company Secretary and as A Board Director, Effective from July 22,2024	23.04.
Arecor to develop "holy grail" diabetes treatment with partner TRx	12.03.
Arecor Therapeutics plc and Trx Biosciences Limited Announces Research Collaboration for the Formulation Development of an Oral GLP-1 Receptor Agonist Product	12.03.
EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV	29.02.
Arecor Therapeutics hails Arestat as 2023 performance "strong"	01.02.
Arecor pleased as investee Inhibrx sells therapy to Sanofi	23.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Arecor Therapeutics plc

Aktien

A3CRY2

GB00BMWLM973

AREC

Andere Sprachen

Filter